• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

KS-NailMel-1:一种新型的甲襞黑色素瘤细胞系。

KS-NailMel-1: a novel cell line of nail apparatus melanoma.

作者信息

Ito Takamichi, Tanaka Yuka, Tanegashima Keiko, Nishio Kiichiro, Hashimoto Hiroki, Ichiki Toshio, Ohno Fumitaka, Kaku-Ito Yumiko, Nakahara Takeshi

机构信息

Department of Dermatology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.

出版信息

Hum Cell. 2025 May 28;38(4):112. doi: 10.1007/s13577-025-01242-7.

DOI:10.1007/s13577-025-01242-7
PMID:40437181
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12119781/
Abstract

Nail apparatus melanoma (NAM) is a specific type of cutaneous melanoma that develops in the nail apparatus of the hands and feet. The prognosis for metastatic NAM is poor due to a lack of fully effective systemic therapies. However, the difficulty in obtaining a NAM model has hindered basic research aimed at discovering effective treatment strategies. In this study, we established a NAM cell line, named KS-NailMel-1, from a primary tumor located on the nail apparatus of the left ring finger of a 68-year-old Japanese female. The cells were successfully maintained for over 9 months, exhibiting a doubling time of 38.6 ± 1.94 h. KS-NailMel-1 displayed consistent growth, spheroid formation, and invasiveness, and was confirmed to be identical to the original tumor through short tandem repeat analyses, whole-exome sequencing, and immunohistochemistry. Western blotting of the cells demonstrated the protein expression of NECTIN4, which has recently attracted attention as a potential therapeutic target for melanoma. The KS-NailMel-1 cell line represents a valuable resource for basic and preclinical research on NAM, deepening our understanding of the tumor characteristics and facilitating the development of treatment strategies for this rare form of cancer.

摘要

甲襞黑色素瘤(NAM)是一种特殊类型的皮肤黑色素瘤,发生于手足的甲襞。由于缺乏完全有效的全身治疗方法,转移性NAM的预后较差。然而,获得NAM模型的困难阻碍了旨在发现有效治疗策略的基础研究。在本研究中,我们从一名68岁日本女性左手无名指甲襞的原发性肿瘤中建立了一个NAM细胞系,命名为KS-NailMel-1。这些细胞成功维持了9个多月,倍增时间为38.6±1.94小时。KS-NailMel-1表现出持续的生长、球体形成和侵袭性,并通过短串联重复序列分析、全外显子测序和免疫组织化学证实与原始肿瘤相同。对这些细胞进行的蛋白质印迹分析显示了NECTIN4的蛋白表达,NECTIN4作为黑色素瘤的潜在治疗靶点最近受到了关注。KS-NailMel-1细胞系是NAM基础研究和临床前研究的宝贵资源,加深了我们对肿瘤特征的理解,并促进了这种罕见癌症治疗策略的开发。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fbd/12119781/a1a8cde21109/13577_2025_1242_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fbd/12119781/e1b48d24cfa7/13577_2025_1242_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fbd/12119781/13462ac78e45/13577_2025_1242_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fbd/12119781/342ad2ed251e/13577_2025_1242_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fbd/12119781/7502c2c10421/13577_2025_1242_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fbd/12119781/ee168ece9c9b/13577_2025_1242_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fbd/12119781/a1a8cde21109/13577_2025_1242_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fbd/12119781/e1b48d24cfa7/13577_2025_1242_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fbd/12119781/13462ac78e45/13577_2025_1242_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fbd/12119781/342ad2ed251e/13577_2025_1242_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fbd/12119781/7502c2c10421/13577_2025_1242_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fbd/12119781/ee168ece9c9b/13577_2025_1242_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fbd/12119781/a1a8cde21109/13577_2025_1242_Fig6_HTML.jpg

相似文献

1
KS-NailMel-1: a novel cell line of nail apparatus melanoma.KS-NailMel-1:一种新型的甲襞黑色素瘤细胞系。
Hum Cell. 2025 May 28;38(4):112. doi: 10.1007/s13577-025-01242-7.
2
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
3
Combined programmed cell death protein 1 and cytotoxic T-lymphocyte associated protein 4 blockade in an international cohort of patients with acral lentiginous melanoma.肢端雀斑样痣黑色素瘤国际患者队列中程序性细胞死亡蛋白1与细胞毒性T淋巴细胞相关蛋白4联合阻断治疗
Br J Dermatol. 2025 Jan 24;192(2):316-326. doi: 10.1093/bjd/ljae401.
4
Sun protection for preventing basal cell and squamous cell skin cancers.预防基底细胞癌和鳞状细胞皮肤癌的防晒措施。
Cochrane Database Syst Rev. 2016 Jul 25;7(7):CD011161. doi: 10.1002/14651858.CD011161.pub2.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
6
St Andrews Referral Delay in Skin Cancer (StARDISC): a study of keratinocyte skin cancer time to treatment, growth, invasiveness, British Association of Dermatologists risk factors and excision adequacy.圣安德鲁斯皮肤癌转诊延迟研究(StARDISC):一项关于角质形成细胞皮肤癌治疗时间、生长、侵袭性、英国皮肤科医师协会危险因素及切除充分性的研究。
Br J Dermatol. 2025 Jun 20;193(1):157-166. doi: 10.1093/bjd/ljaf097.
7
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
9
Neoadjuvant treatment for stage III and IV cutaneous melanoma.新辅助治疗 III 期和 IV 期皮肤黑色素瘤。
Cochrane Database Syst Rev. 2023 Jan 17;1(1):CD012974. doi: 10.1002/14651858.CD012974.pub2.
10
Incentives for preventing smoking in children and adolescents.预防儿童和青少年吸烟的激励措施。
Cochrane Database Syst Rev. 2017 Jun 6;6(6):CD008645. doi: 10.1002/14651858.CD008645.pub3.

引用本文的文献

1
An Operational Status Assessment Model for SF High-Voltage Circuit Breakers Based on IAR-BTR.基于IAR-BTR的SF高压断路器运行状态评估模型
Sensors (Basel). 2025 Jun 25;25(13):3960. doi: 10.3390/s25133960.

本文引用的文献

1
European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2024.欧洲基于共识的黑色素瘤跨学科指南。第2部分:治疗——2024年更新
Eur J Cancer. 2025 Jan 17;215:115153. doi: 10.1016/j.ejca.2024.115153. Epub 2024 Nov 29.
2
European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics - Update 2024.欧洲基于共识的黑色素瘤跨学科指南。第1部分:诊断——2024年更新版
Eur J Cancer. 2025 Jan 17;215:115152. doi: 10.1016/j.ejca.2024.115152. Epub 2024 Nov 28.
3
KS-cSCC-1 and KS-cSCC-2: two novel cutaneous squamous cell carcinoma cell lines established from Japanese patients.
KS-cSCC-1和KS-cSCC-2:从日本患者中建立的两种新型皮肤鳞状细胞癌细胞系。
Front Med (Lausanne). 2024 Nov 7;11:1483450. doi: 10.3389/fmed.2024.1483450. eCollection 2024.
4
Shortened progression free and overall survival to immune-checkpoint inhibitors in BRAF-, RAS- and NF1- ("Triple") wild type melanomas.BRAF、RAS 和 NF1(“三重”)野生型黑色素瘤中免疫检查点抑制剂的无进展生存期和总生存期缩短。
Eur J Cancer. 2024 Sep;208:114208. doi: 10.1016/j.ejca.2024.114208. Epub 2024 Jul 6.
5
NECTIN4-targeted antibody-drug conjugate is a potential therapeutic option for extramammary Paget disease.NECTIN4 靶向抗体药物偶联物是一种治疗乳房外派杰病的潜在治疗选择。
Exp Dermatol. 2024 Mar;33(3):e15049. doi: 10.1111/exd.15049.
6
Cutaneous melanoma.皮肤黑素瘤。
Lancet. 2023 Aug 5;402(10400):485-502. doi: 10.1016/S0140-6736(23)00821-8. Epub 2023 Jul 24.
7
KS-EMPD-1: a novel cell line of primary extramammary Paget's disease.KS-EMPD-1:一种原发性外阴 Paget 病的新型细胞系。
Hum Cell. 2023 Sep;36(5):1813-1829. doi: 10.1007/s13577-023-00951-1. Epub 2023 Jul 11.
8
Nail Apparatus Melanoma: Current Management and Future Perspectives.甲襞黑色素瘤:当前治疗与未来展望
J Clin Med. 2023 Mar 12;12(6):2203. doi: 10.3390/jcm12062203.
9
Human epidermal growth factor receptor 3 serves as a novel therapeutic target for acral melanoma.人表皮生长因子受体3是肢端黑色素瘤的一个新的治疗靶点。
Cell Death Discov. 2023 Feb 10;9(1):54. doi: 10.1038/s41420-023-01358-5.
10
Immunotherapy for Melanoma: The Significance of Immune Checkpoint Inhibitors for the Treatment of Advanced Melanoma.黑色素瘤的免疫治疗:免疫检查点抑制剂在晚期黑色素瘤治疗中的意义。
Int J Mol Sci. 2022 Dec 11;23(24):15720. doi: 10.3390/ijms232415720.